{"id":"W2588014405","doi":"10.1111/bjd.15381","title":"Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Dermatology Life Quality Index; Internal medicine; Psoriasis Area and Severity Index; Psoriasis; Clinical endpoint; Confidence interval; Quality of life (healthcare); Visual analogue scale; Severity of illness; Surgery; Gastroenterology; Physical therapy; Randomized controlled trial; Dermatology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003394492,0.001435806,0.002932708,0.0003786715,0.0004399096,0.0009877274,0.0008242304,0.001265297,0.005365039],"category_scores_gemma":[0.002519485,0.0007520173,0.001663383,0.0003409014,0.001087841,0.001225011,0.0004463845,0.002671574,0.0009666963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006872247,"about_ca_system_score_gemma":0.0009448072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004306503,"about_ca_topic_score_gemma":0.000628728,"domain_scores_codex":[0.9984362,0.0009184196,0.00009688014,0.0002529706,0.0001474293,0.0001481148],"domain_scores_gemma":[0.9973875,0.0007938578,0.0005941299,0.0003182269,0.0001422014,0.000764182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.892094,0.06136869,0.006762214,0.0004230103,0.0009673767,0.0001303727,0.0001528008,0.0005523225,0.006071488,0.00009242417,0.0006789835,0.0307063],"study_design_scores_gemma":[0.5975166,0.3849228,0.01455599,0.00002490173,0.0002678184,0.0001467218,0.0000400375,0.001042789,0.0005090191,0.00009339936,0.0008547922,0.00002513704],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953708,0.001025927,0.0005096256,0.0001426208,0.00009406004,0.001519872,0.0005948126,0.00004601939,0.0006961897],"genre_scores_gemma":[0.9930795,0.00051991,0.001147454,0.0004152916,0.0002589786,0.002346985,0.0009230604,0.00001106025,0.001297738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005365039,"threshold_uncertainty_score":0.01795202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02431952875704098,"score_gpt":0.2726811910916362,"score_spread":0.2483616623345953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}